These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2872912)

  • 21. Raynaud's Syndrome: a neglected disease.
    Poredos P; Poredos P
    Int Angiol; 2016 Apr; 35(2):117-21. PubMed ID: 25673314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of Raynaud's phenomenon with alpha-lytic agents].
    Clément DL
    Rev Med Liege; 1980 Oct; 35(19):650-2. PubMed ID: 6109369
    [No Abstract]   [Full Text] [Related]  

  • 23. Raynaud's phenomenon: Current concepts.
    Stringer T; Femia AN
    Clin Dermatol; 2018; 36(4):498-507. PubMed ID: 30047433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Raynaud's phenomenon: clinical aspects of the disease].
    Konychev AV; Koreshkina TA; Kokorin KV; Kaiukov AV
    Vestn Khir Im I I Grek; 2001; 160(2):118-22. PubMed ID: 11496483
    [No Abstract]   [Full Text] [Related]  

  • 25. Geriatrics photo quiz. Raynaud's: classic "blue fingertips'.
    Gross JS; Shua-Haim JR
    Geriatrics; 1996 May; 51(5):10, 21. PubMed ID: 8621099
    [No Abstract]   [Full Text] [Related]  

  • 26. Managing Raynaud's phenomenon: a practical approach.
    Adee AC
    Am Fam Physician; 1993 Mar; 47(4):823-9. PubMed ID: 8438681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What's new in the management of Raynaud's phenomenon.
    Sessoms S; Kovarsky J
    Tex Med; 1982 Nov; 78(11):44-6. PubMed ID: 7179166
    [No Abstract]   [Full Text] [Related]  

  • 28. [Calcium antagonists in Raynaud's disease].
    Gjørup T; Hartling OJ; Kelbaek H; Nielsen SL
    Ugeskr Laeger; 1986 Nov; 148(48):3236-7. PubMed ID: 3544411
    [No Abstract]   [Full Text] [Related]  

  • 29. [Raynaud's phenomenon: effects of terazosin].
    Paterna S; Pinto A; Arrostuto A; Cannavò MG; Di Pasquale P; Cottone C; Licata G
    Minerva Cardioangiol; 1997 May; 45(5):215-21. PubMed ID: 9273472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raynaud's phenomenon: peripheral catecholamine concentration and effect of sympathectomy.
    Nielsen SL; Christensen NJ; Olsen N; Lassen NA
    Acta Chir Scand Suppl; 1980; 502():57-62. PubMed ID: 6941602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Calcium antagonists in the treatment of Raynaud's syndrome and in the treatment of esophageal spasm].
    Kahan A; Amor B; Menkès CJ
    Rev Prat; 1988 Nov; 38(27):1986-8. PubMed ID: 3206151
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical inquiries. What is the evaluation and treatment strategy for Raynaud's phenomenon?
    Tagliarino H; Purdon M; Jamieson B; Hoekzema G
    J Fam Pract; 2005 Jun; 54(6):553-5. PubMed ID: 15939010
    [No Abstract]   [Full Text] [Related]  

  • 33. [How I treat...Raynaud's phenomenon].
    Piérard GE
    Rev Med Liege; 1998 Mar; 53(3):119-20. PubMed ID: 9594609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raynaud's phenomenon.
    O'connor CM
    J Vasc Nurs; 2001 Sep; 19(3):87-92; quiz 93-4. PubMed ID: 11533581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Raynaud's phenomenon with calcium channel blockers.
    Smith CR; Rodeheffer RJ
    Am J Med; 1985 Feb; 78(2B):39-42. PubMed ID: 3976694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raynaud's phenomenon: pathophysiologic features and treatment with calcium-channel blockers.
    Smith CR; Rodeheffer RJ
    Am J Cardiol; 1985 Jan; 55(3):154B-157B. PubMed ID: 3881908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raynaud's phenomenon.
    DE TAKATS G; FOWLER EF
    Bull Soc Int Chir; 1962; 21():73-80. PubMed ID: 13884559
    [No Abstract]   [Full Text] [Related]  

  • 38. Raynaud's phenomenon treated with sympathectomy. A follow-up study of 28 patients.
    HALL KV; HILLESTAD LK
    Angiology; 1960 Jun; 11():186-9. PubMed ID: 14399052
    [No Abstract]   [Full Text] [Related]  

  • 39. New lines in therapy of Raynaud's phenomenon.
    Lambova SN; Müller-Ladner U
    Rheumatol Int; 2009 Feb; 29(4):355-63. PubMed ID: 19037602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The therapy of Raynaud's phenomenon].
    Di Giacinto G
    Clin Ter; 1993 Feb; 142(2):161-74. PubMed ID: 8472530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.